Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in financing to advance its research and development. CEO Dr. John Swart announced ...
A new study suggests that a naturally occurring compound made by healthy gut bacteria may help protect children from developing fatty liver disease later in life. Children whose mothers eat diets high ...
A study reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic ...
Organoids are small-scale models that mimic human organs. These models could help scientists understand diseases and test treatments, and potentially aid in regenerative therapeutic methods. Organoids ...
Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk of ...
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...
Myosteatosis is associated with poor outcomes in various liver diseases. However, standardized methods for assessing, defining, and diagnosing myosteatosis in the context of liver diseases remain ...
Your liver works tirelessly as your body’s natural filtration system, processing everything you consume and protecting you from harmful substances. When it comes to alcohol, however, this remarkable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback